Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation

Toxicological Sciences : an Official Journal of the Society of Toxicology
Ana P Ferragut CardosoJ Christopher States

Abstract

Arsenic is a toxic metalloid widely present in the earth's crust, and is a proven human carcinogen. Chronic arsenic exposure mainly through drinking water causes skin, lung, and urinary bladder cancers, and is associated with liver, prostate, and kidney cancers, cardiovascular and neurological disorders, and diabetes. Several modes of action have been suggested in arsenic carcinogenesis. However, the molecular etiology of arsenic-induced cancer remains unclear. Recent evidence clearly indicates that gene expression modifications induced by arsenic may involve epigenetic alterations, including miRNA dysregulation. Many miRNAs have been implicated in different human cancers as a consequence of losses and or gains of miRNA function that contribute to cancer development. Progress in identifying miRNA dysregulation induced by arsenic has been made using different approaches and models. The present review discusses the recent data regarding dysregulated expression of miRNA in arsenic-induced malignant transformation in vitro, gaps in current understanding and deficiencies in current models for arsenic-induced carcinogenesis, and future directions of research that would improve our knowledge regarding the mechanisms involved in arseni...Continue Reading

References

Apr 6, 2004·Environmental Health Perspectives·Fredric J BurnsToby G Rossman
Nov 17, 2006·Cancer Research·Carmen J MarsitKarl T Kelsey
May 18, 2007·Annual Review of Cell and Developmental Biology·Natascha Bushati, Stephen M Cohen
Oct 19, 2007·Cancer Research·Valerie B SampsonLeslie J Krueger
Aug 23, 2008·Cell Cycle·Craig D LottermanJoshua T Mendell
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
Oct 17, 2009·Gut·T ParanjapeJ B Weidhaas
Jun 2, 2010·Epigenomics·John F Reichard, Alvaro Puga
Jun 15, 2010·Molecular Cell·Wenwei HuZhaohui Feng
Aug 5, 2010·Environmental Health Perspectives·Xuefeng RenLuoping Zhang
Nov 9, 2010·Biochemical and Biophysical Research Communications·Shen-meng GaoLei Jiang
May 3, 2011·Current Genomics·Leigh-Ann Macfarlane, Paul R Murphy
May 4, 2012·Spermatogenesis·Gurvinder Kaur, Jannette M Dufour
Dec 4, 2012·Genomics, Proteomics & Bioinformatics·Yu Li, Kris V Kowdley
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Samy LamouilleRik Derynck
May 27, 2014·Current Environmental Health Reports·Kathryn A Bailey, Rebecca C Fry
Jul 16, 2014·Nature Reviews. Genetics·Jean Hausser, Mihaela Zavolan
Jul 17, 2014·Nature Reviews. Molecular Cell Biology·Minju Ha, V Narry Kim
Jul 17, 2014·Trends in Molecular Medicine·Josie HayesSean Lawler
Dec 17, 2014·Biochemical and Biophysical Research Communications·Zhuo ZhangXianglin Shi
Jan 15, 2015·Cancer Prevention Research·Christina MichailidiMohammad Obaidul Hoque
Jan 28, 2015·Toxicology and Applied Pharmacology·Xuefeng RenHongmei Wu
Mar 23, 2015·Biological Trace Element Research·J Christopher States
May 12, 2015·Cancer Cell International·Kaladhar B Reddy
Dec 15, 2015·Cancer Discovery·Charles J SherrGeoffrey I Shapiro
Oct 30, 2016·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Brock HumphriesChengfeng Yang
Mar 14, 2017·Oncogene·M Fischer

❮ Previous
Next ❯

Citations

Aug 16, 2018·Biological Trace Element Research·Jafar GolmohammadiMehdi Aliomrani
Oct 14, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jeanne M DanesMarcelo G Bonini
Mar 13, 2021·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Elida Cristina Monteiro De OliveiraBoscolli Barbosa Pereira
Apr 11, 2020·Chemical Research in Toxicology·Mayukh BanerjeeJ Christopher States

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.